Grifols continues the European Alpha-1-Antitrypsin Laurell’s
Training Award (eALTA) program to support basic and clinical research and education through grants. By offering this program, Grifols proudly demonstrates its commitment to the Alpha-1 community to provide new insights into Alpha-1-Antitrypsin Deficiency (AATD) and helps to identify new standards of care for this disease.
A primary goal of the eALTA program is to identify and support research projects aimed at enhancing the understanding of disease mechanisms of AATD and associated disorders and to help improving existing as well as finding new therapies.
The competitive eALTA fellowships offer promising young clinicians and scientists the opportunity to embark on research projects in the extended field of AATD, irrespective of whether they are new or already established in this exciting area of research.
Another objective of the eALTA award is to strengthen and further extend the existing network between clinical and scientific centres as well as individuals working in the field of AATD and to facilitate collaborations.
If you are passionate about embarking on Alpha-1-Antitrypsin research, you should consider applying for the eALTA Award 2014. The aims, conditions of participation and deadlines are outlined on About eALTA Award
Make the most of this outstanding opportunity. Join us, together for life, together for European Scientific Progress – continuous commitment to innovative research in Alpha-1-Antitrypsin Deficiency.
The program is run in collaboration with the Alpha One International Registry (AIR)